Shopping Cart
- Remove All
- Your shopping cart is currently empty
Vandortuzumab is a humanised monoclonal antibody targeting STEAP1, commonly used as the targeting component of the synthetic ADC (antibody-drug conjugate) vandortuzumab vedotin, and is applicable for prostate cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $247 | In Stock | |
5 mg | $745 | In Stock | |
10 mg | $1,180 | In Stock | |
25 mg | $1,770 | In Stock | |
50 mg | $2,380 | In Stock |
Description | Vandortuzumab is a humanised monoclonal antibody targeting STEAP1, commonly used as the targeting component of the synthetic ADC (antibody-drug conjugate) vandortuzumab vedotin, and is applicable for prostate cancer research. |
Molecular Weight | 145.5 kDa |
Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.